18 February 2002: The Regional Competent Authority issues a positive adviceFile: b-be-02-b7-2013-advice-of-the-regional-competent.pdfTrial reference: Phase II study evaluating the clinical efficacy of TG4010 (MVA-MUC1-IL2) in patients with metastatic Renal Cell Carcinoma (RCC) Doc type: Information related to the decision procedure
